190A.T
Price:
$229
Market Cap:
$15.80B
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales.
Industry
Medical - Pharmaceuticals
IPO Date
Stock Exchange
JPX
Ticker
190A.T
According to Chordia Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.34. This represents a change of -36.42% compared to the average of -11.54 of the last 4 quarters.
The mean historical PE Ratio of Chordia Therapeutics Inc. over the last ten years is 1.47. The current -7.34 PE Ratio has changed -49902.59% with respect to the historical average. Over the past ten years (40 quarters), 190A.T's PE Ratio was at its highest in in the May 2023 quarter at 0. The PE Ratio was at its lowest in in the August 2024 quarter at -20.31.
Average
1.47
Median
-8.78
Minimum
-25.07
Maximum
48.52
Discovering the peaks and valleys of Chordia Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 48.52
Minimum Annual Increase = -1105.33%
Minimum Annual PE Ratio = -25.07
Year | PE Ratio | Change |
---|---|---|
2024 | -25.07 | -151.67% |
2023 | 48.52 | -1105.33% |
2022 | -4.83 | -62.08% |
The current PE Ratio of Chordia Therapeutics Inc. (190A.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.21
5-year avg
1.47
10-year avg
1.47
Chordia Therapeutics Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chordia Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chordia Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Chordia Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Chordia Therapeutics Inc. (190A.T)?
What is the highest PE Ratio for Chordia Therapeutics Inc. (190A.T)?
What is the 3-year average PE Ratio for Chordia Therapeutics Inc. (190A.T)?
What is the 5-year average PE Ratio for Chordia Therapeutics Inc. (190A.T)?
How does the current PE Ratio for Chordia Therapeutics Inc. (190A.T) compare to its historical average?